Lawsuit Seeking FDA Triclosan Action Stays Alive On Appeal
This article was originally published in The Tan Sheet
Executive Summary
A court ruling allowing an advocacy group to move forward in its suit against FDA could pave the way for future litigation intended to force the agency to complete delayed regulations.
You may also be interested in...
California DTSC’s Draft Work Plan Includes Personal Care, But Few Surprises
“Beauty, personal care and hygiene” as one of seven product categories could be priorities in the next round of product selections in California’s Safer Consumer Products program. PCPC welcomes the direction DTSC appears to be taking toward more active industry engagement over the next three years.
California DTSC’s Draft Work Plan Includes Personal Care, But Few Surprises
“Beauty, personal care and hygiene” as one of seven product categories could be priorities in the next round of product selections in California’s Safer Consumer Products program. PCPC welcomes the direction DTSC appears to be taking toward more active industry engagement over the next three years.
FDA’s Top Agenda Maker: Commissioner, Congress – Or The Courts?
Agency chief counsel says continued priority-setting through lawsuits eventually may affect public health, while professor says FDA discretion not to act is at stake in some cases.